{"transactions":[{"id":723861,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T20:43:29.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date."}],"balance_after":35000,"derivative":{"exercise_price":4.7,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001250086-26-000002","document":"form4-06292026_080624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250086/000125008626000002/form4-06292026_080624.xml","form_type":"4"}},{"id":1099134,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T21:00:15.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 26, 2026, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date."}],"balance_after":25000,"derivative":{"exercise_price":4.18,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-018522","document":"form4-06302025_050611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250086/000141588925018522/form4-06302025_050611.xml","form_type":"4"}},{"id":1468032,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T21:02:53.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 25, 2025, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date."}],"balance_after":18000,"derivative":{"exercise_price":16.87,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001415889-24-018347","document":"form4-06272024_090647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250086/000141588924018347/form4-06272024_090647.xml","form_type":"4"}},{"id":1473208,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T16:14:28.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 18, 2024. The shares underlying the option are scheduled to vest as to 100% of the shares on June 18, 2025, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date."}],"balance_after":28000,"derivative":{"exercise_price":4.4,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000950170-24-075581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000095017024075581/ownership.xml","form_type":"4"}},{"id":1656650,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-06T22:58:20.000Z","date":"2024-02-02","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option shall vest and become exercisable on November 2, 2024, and 1/48th of the shares underlying the option shall vest in equal monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":36000,"derivative":{"exercise_price":17,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001209191-24-002930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250086/000120919124002930/doc4.xml","form_type":"4"}},{"id":1854362,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T16:05:20.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 13, 2023. The shares underlying the option are scheduled to vest as to 100% of the shares on June 13, 2024,\nor, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date."}],"balance_after":16000,"derivative":{"exercise_price":6.18,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-23-037298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919123037298/doc4.xml","form_type":"4"}},{"id":2232703,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-14T07:47:16.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":9367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 10, 2022. The shares underlying the option are scheduled to vest as to 100% of the shares on June 10, 2023, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date."}],"balance_after":9367,"derivative":{"exercise_price":4.38,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":9367},"source":{"system":"sec-edgar","filing":"0001209191-22-036566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919122036566/doc4.xml","form_type":"4"}},{"id":2655876,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-24T16:11:00.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":9367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 23, 2021. The shares underlying the option are scheduled to vest as to 100% of the shares on June 23, 2022, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date."}],"balance_after":9367,"derivative":{"exercise_price":17.12,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":9367},"source":{"system":"sec-edgar","filing":"0001209191-21-043004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000120919121043004/doc4.xml","form_type":"4"}},{"id":3076256,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":34785,"kind":"person","name":"DIAZ REINALDO M","position":1,"cik":"0001250086","reported_name":"DIAZ REINALDO M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-24T16:46:18.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":9367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 23, 2020. The shares underlying the option are scheduled to vest as to 100% of the shares on July 23, 2021, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date."}],"balance_after":9367,"derivative":{"exercise_price":16,"expiration_date":"2030-07-22","underlying":"Common Stock","underlying_shares":9367},"source":{"system":"sec-edgar","filing":"0000899243-20-020393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924320020393/doc4.xml","form_type":"4"}}]}